| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research |
1 All authors: Department of Radiology, Breast Imaging Section, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021.
OBJECTIVE. The purpose of this study was to determine the impact of lesion size on the positive predictive value (PPV) of biopsy in MRI-detected breast lesions.
MATERIALS AND METHODS. A retrospective review was performed of 666 consecutive nonpalpable, mammographically occult lesions that had MRI-guided localization. MRI examinations were performed using a 1.5-T magnet. Lesions were measured by the interpreting radiologist before biopsy. Malignancy rate versus lesion size was determined.
RESULTS. The median MRI lesion size was 1 cm (range, 0.3-7.0 cm). Malignancy was present in 149/666 (22%) lesions, of which 80 (54%) were ductal carcinoma in situ (DCIS), 66 (44%) were invasive cancer, and three (2%) were lymphoma. The frequency of malignancy increased significantly (p = 0.0005) with lesion size, with malignancy found in one (3%) of 37 lesions less than 5 mm, 44 (17%) of 254 lesions 5-9 mm, 37 (25%) of 151 lesions 10-14 mm, 21 (28%) of 74 lesions 15-19 mm, and 46 (31%) of 150 lesions 20 mm or larger. Lesions less than 5 mm accounted for 37 (6%) of 666 lesions that had a biopsy and one (< 1%) of 149 cancers (one DCIS). Among lesions less than 10 mm, the likelihood of malignancy was highest in postmenopausal women (22% malignant) and in the extent of disease setting (22% malignant), and lowest in premenopausal women (10% malignant) and in the high-risk screening setting (10% malignant).
CONCLUSION. The PPV of biopsy for lesions identified at breast MRI using a 1.5-T magnet significantly increased with increasing lesion size. Biopsy is rarely necessary for lesions smaller than 5 mm because of their low (3%) likelihood of cancer. Further work is needed to develop an algorithm that uses size in addition to other patient and lesion factors to guide biopsy recommendations for MRI-detected breast lesions.
Keywords: breast • breast cancer • breast imaging • MRI • oncologic imaging
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Preda, S. Rizzo, M. Bellomi, W. Tse Yang, and H. T. Le-Petross MR Imaging of Breast Lymphoma Radiology, July 1, 2008; 248(1): 320 - 321. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hoogerbrugge, Y. J. L. Kamm, P. Bult, K. M. Landsbergen, E. M. H. F. Bongers, H. G. Brunner, H. J. Bonenkamp, J. A. de Hullu, M. J. L. Ligtenberg, and C. Boetes The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited Ann. Onc., April 1, 2008; 19(4): 655 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Javid, J. W. Carlson, J. E. Garber, R. L. Birdwell, S. Lester, S. Lipsitz, and M. Golshan Breast MRI Wire-Guided Excisional Biopsy: Specimen Size as Compared to Mammogram Wire-Guided Excisional Biopsy and Implications for Use. Ann. Surg. Oncol., December 1, 2007; 14(12): 3352 - 3358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. B. Bevilacqua, M. W. Kattan, J. V. Fey, H. S. Cody III, P. I. Borgen, and K. J. Van Zee Doctor, What Are My Chances of Having a Positive Sentinel Node? A Validated Nomogram for Risk Estimation J. Clin. Oncol., August 20, 2007; 25(24): 3670 - 3679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. A. J. Van den Bosch, D. M. Ikeda, and B. L. Daniel Does Size Matter? Likelihood of Cancer in MRI-Detected Lesions Less Than 5 mm Am. J. Roentgenol., June 1, 2007; 188(6): W571 - W571. [Full Text] [PDF]
|
|
|
|
|
|
F. Pediconi, C. Catalano, A. Roselli, S. Padula, F. Altomari, E. Moriconi, A. M. Pronio, M. A. Kirchin, and R. Passariello Contrast-enhanced MR Mammography for Evaluation of the Contralateral Breast in Patients with Diagnosed Unilateral Breast Cancer or High-Risk Lesions Radiology, June 1, 2007; 243(3): 670 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Plevritis, D. M. Ikeda, and A. M. Garber Cost-effectiveness of Breast Magnetic Resonance Imaging to Screen BRCA1/2 Mutation Carriers--Reply JAMA, December 13, 2006; 296(22): 2682 - 2682. [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. ODLE Breast MR Radiol. Technol., September 1, 2006; 78(1): 45M - 66M. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
